Metformin salts of 2,4-thiazolidinediones are described for the treatment of diabetes mellitus Type2, gestational diabetes, polycystic ovary syndrome, non-alcoholic fatty liver disease, coronary artery disease, pancreatic cancer, premature puberty, and other diseases which manifest insulin resistance.

Energy storage is accomplished by producing hydrazine carbonate and later reconverting the hydrazine carbonate to release the energy. Sea water is firstly used in an electrolysis process to prepare hypochlorite. The hypochlorite reacts as a result of introduction of ammonia to produce monochloramine and then hydrazine. The hydrazine reacts as a result of introduction of carbon dioxide to give hydrazine carbonate. To release the energy, the hydrazine carbonate liberates hydrogen or at least a hydrogen-containing gas by reaction over a noble metal-free catalyst. The hydrogen may then be enriched before being fed to a fuel cell.

Energy storage is accomplished by producing hydrazine carbonate and later reconverting the hydrazine carbonate to release the energy. Sea water is firstly used in an electrolysis process to prepare hypochlorite. The hypochlorite reacts as a result of introduction of ammonia to produce monochloramine and then hydrazine. The hydrazine reacts as a result of introduction of carbon dioxide to give hydrazine carbonate. To release the energy, the hydrazine carbonate liberates hydrogen or at least a hydrogen-containing gas by reaction over a noble metal-free catalyst. The hydrogen may then be enriched before being fed to a fuel cell.

The invention relates to the compound of ##STR00001##
or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for treating or preventing neuromuscular disorders and neurodegenerative diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, or parenteral-administration, or syrup, or injection. Such compositions may be used to treatment or management of neuromuscular disorders and neurodegenerative diseases such as Parkinson's disease, scleroderma, restless leg syndrome, hypertension and gestational hypertension.